Jazz Pharmaceuticals
JAZZ
#2029
Rank
$7.50 B
Marketcap
$120.42
Share price
-0.07%
Change (1 day)
-15.55%
Change (1 year)

P/S ratio for Jazz Pharmaceuticals (JAZZ)

P/S ratio as of March 2024 (TTM): 1.96

According to Jazz Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.96165. At the end of 2023 the company had a P/S ratio of 2.02.

P/S ratio history for Jazz Pharmaceuticals from 2007 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20232.02-26.32%
20222.748.31%
20212.53-35.48%
20203.921.18%
20193.882.84%
20183.77-24.41%
20174.9913.64%
20164.39-32.53%
20156.50-23.17%
20148.470.87%
20138.3959.2%
20125.27-11.86%
20115.9832.17%
20104.53136.01%
20091.92173.21%
20080.7018-87.3%
20075.53

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.88 97.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
0.1421-92.76%๐Ÿ‡บ๐Ÿ‡ธ USA
0.0000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
0.9982-49.12%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel